Literature DB >> 334342

Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.

L Tougaard, E Sörensen, J Bröchner-Mortensen, M S Christensen, P Rödbro, A W Sörensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 334342     DOI: 10.1007/bf02064048

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


× No keyword cloud information.
  8 in total

1.  Bone mineral content in the forearm measured by photon absorptiometry. Principles and reliability.

Authors:  C Christiansen; P Rödbro; H Jensen
Journal:  Scand J Clin Lab Invest       Date:  1975-07       Impact factor: 1.713

2.  The degree of mineralization in normal bone tissue estimated as the phosphorus to hydroxyproline ratio.

Authors:  L Tougaard
Journal:  Scand J Clin Lab Invest       Date:  1975-05       Impact factor: 1.713

3.  A simple method for the determination of glomerular filtration rate.

Authors:  J Bröchner-Mortensen
Journal:  Scand J Clin Lab Invest       Date:  1972-11       Impact factor: 1.713

4.  A sensitive radioimmunoassay of parathyroid hormone in human serum using a specific extraction procedure.

Authors:  M S Christensen
Journal:  Scand J Clin Lab Invest       Date:  1976-07       Impact factor: 1.713

5.  I alpha-hydroxycholecalciferol: a treatment of renal bone disease.

Authors:  G R Catto; M MacLeod; B Pelc; E Kodicek
Journal:  Br Med J       Date:  1975-01-04

6.  Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.

Authors:  A M Pierides; H A Ellis; W Simpson; J H Dewar; M K Ward; D N Kerr
Journal:  Lancet       Date:  1976-05-22       Impact factor: 79.321

7.  Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.

Authors:  L Tougaard; E Sorensen; J Brochner-Mortensen; M S Christensen; P Rodbro; A W Sorensen
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

8.  1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure.

Authors:  A S Brickman; J W Coburn; S G Massry; A W Norman
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.